Ambev S.A. Files October 2025 6-K Report

TL;DR

Ambev S.A. (ABEV) filed its October 6-K, confirming 20-F reporting and Brazilian HQ.

AI Summary

Ambev S.A. filed a Form 6-K on October 7, 2025, for the month of October 2025. This report is for a foreign private issuer and indicates that Ambev S.A. files annual reports under Form 20-F. The company's principal executive office is located in Sao Paulo, Brazil.

Why It Matters

This filing provides routine disclosure for Ambev S.A. as a foreign private issuer, informing investors about its reporting status and location.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain material new financial information or significant corporate events.

Key Players & Entities

• AMBEV S.A. (company) — Registrant
• 0001565025 (company) — Central Index Key
• Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor (company) — Principal executive office address
• Sao Paulo, SP, Federative Republic of Brazil (company) — Location of principal executive office
• 20251007 (date) — Filing date

FAQ

Filing Documents

• abevcvm358sep25_6k.htm (6-K) — 48KB
• 0001292814-25-003482.txt ( ) — 49KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the month of October, 2025 Commission File Number 1565025 AMBEV S.A. (Exact name of registrant as specified in its charter) AMBEV S.A. (Translation of Registrant's name into English) Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ___X___ Form 40-F _______ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _______ No ___X____ INDIVIDUAL FORM Article 11 - CVM Instruction # 358/2002 In September 2025: (X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1) ( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows. Company Name: Ambev S.A. Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00 Qualification: Outstanding Shares in Treasury Initial Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 169,352,327 ADR Common 0.00 Transactions in the month Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3) Shares Common Direct with company Delivery of restricted shares 02 146,923 12,30 1,807,152.90 Final Balance Securities / Derivatives Securities Characteristics (2) Quantity Shares Common 169,205,404 ADR Common 0 (1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information, (2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others, (3) Quantity multiplied by price, (*) Each ADR is equivalent to 1 (one) share, SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 7, 2025 AMBEV S.A. By: /s/ Guilherme Fleury de Figueiredo Ferraz Parolari Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer

View Full Filing

View this 6-K filing on SEC EDGAR